Kory P et al., 2021-05: The FLCCC authors' narrative review assembling peer-reviewed trials, preprints, meta-analyses and regional 'natural experiment' data to argue that ivermectin is effective for COVID-19 prophylaxis and treatment.
A large majority of randomized and observational controlled trials of ivermectin are reporting repeated, large magnitude improvements in clinical outcomes.
Kory P et al., 2021-05: The FLCCC authors' narrative review assembling peer-reviewed trials, preprints, meta-analyses and regional 'natural experiment' data to argue that ivermectin is effective for COVID-19 prophylaxis and treatment. Narrative review (not a systematic review) by five Front Line COVID-19 Critical Care Alliance physicians. It draws on published studies, manuscripts posted to preprint servers, expert meta-analyses and epidemiological analyses of regions with distribution campaigns. Authors declare: 'The authors have no conflicts of interest to declare.' No study population of its own. The review's reliance on preprint and observational data is what later critiques (IVE-44, IVE-45) target; it was not retracted. This is the document most often cited in support of the FLCCC position. Study type: review.
